- Home
- MBOT vs GNFT Comparison
MBOT vs GNFT Comparison
Compare MBOT & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- GNFT
- Stock Information
- Founded
- MBOT 2010
- GNFT 1999
- Country
- MBOT United States
- GNFT France
- Employees
- MBOT N/A
- GNFT N/A
- Industry
- MBOT Medical/Dental Instruments
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MBOT Health Care
- GNFT Health Care
- Exchange
- MBOT Nasdaq
- GNFT Nasdaq
- Market Cap
- MBOT 184.8M
- GNFT 216.7M
- IPO Year
- MBOT N/A
- GNFT 2019
- Fundamental
- Price
- MBOT $2.27
- GNFT $4.14
- Analyst Decision
- MBOT Strong Buy
- GNFT Strong Buy
- Analyst Count
- MBOT 1
- GNFT 2
- Target Price
- MBOT $12.00
- GNFT $10.00
- AVG Volume (30 Days)
- MBOT 2.9M
- GNFT 5.0K
- Earning Date
- MBOT 11-13-2025
- GNFT 09-22-2025
- Dividend Yield
- MBOT N/A
- GNFT N/A
- EPS Growth
- MBOT N/A
- GNFT N/A
- EPS
- MBOT N/A
- GNFT N/A
- Revenue
- MBOT N/A
- GNFT $52,994,715.00
- Revenue This Year
- MBOT N/A
- GNFT $3.14
- Revenue Next Year
- MBOT $1,107.73
- GNFT N/A
- P/E Ratio
- MBOT N/A
- GNFT N/A
- Revenue Growth
- MBOT N/A
- GNFT N/A
- 52 Week Low
- MBOT $0.89
- GNFT $2.55
- 52 Week High
- MBOT $4.67
- GNFT $6.03
- Technical
- Relative Strength Index (RSI)
- MBOT 28.59
- GNFT 49.76
- Support Level
- MBOT $2.06
- GNFT $4.07
- Resistance Level
- MBOT $2.57
- GNFT $4.24
- Average True Range (ATR)
- MBOT 0.16
- GNFT 0.14
- MACD
- MBOT -0.05
- GNFT -0.01
- Stochastic Oscillator
- MBOT 16.33
- GNFT 41.70
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.